Difference between revisions of "Part:BBa K2052016"
Goksubayrak (Talk | contribs) |
|||
| Line 3: | Line 3: | ||
<partinfo>BBa_K2052016 short</partinfo> | <partinfo>BBa_K2052016 short</partinfo> | ||
| − | + | ||
| − | + | ||
| Line 13: | Line 12: | ||
FimH protein is a subunit of a structure called pilus, which naturally occurs in some | FimH protein is a subunit of a structure called pilus, which naturally occurs in some | ||
| − | strains of e.coli. This protein coding sequence made our bacteria to have fimH adhesin. | + | strains of e.coli. This protein coding sequence made our bacteria to have fimH adhesin. Normally, in pathogenic strains of E.coli, at the end of each pilus, there is a carbohydrate binding protein “Lectin” which allows the binding to sugar mannose. However, we used a non- pathogenic strain BL21 in our project so it doesn’t contain Lectin in it’s pili. Thus our bacteria isn’t able to bind to bind to any non-cancerous eukaryotic cells even though it had fimH. Then, to make the binding system cancer specific and to make our bacteria bind only to cancerous cells, we used RPMrel. RPMrel is a 9 amino acid colon tumor specific binding heptapeptide. It was used for controlling preferential binding to poorly-differentiated colon carcinoma cells. (1) |
| − | + | ||
| − | Normally, in pathogenic strains of E.coli, at the end of each pilus, there is a carbohydrate binding protein “Lectin” which allows the binding to sugar mannose. However, we used a non- pathogenic strain BL21 in our project so it doesn’t contain Lectin in it’s pili. Thus our bacteria isn’t able to bind to bind to any non-cancerous eukaryotic cells even though it had fimH. Then, to make the binding system cancer specific and to make our bacteria bind only to cancerous cells, we used RPMrel. RPMrel is a 9 amino acid colon tumor specific binding heptapeptide. It was used for controlling preferential binding to poorly-differentiated colon carcinoma cells. (1) | + | |
The part includes a double terminator (BBa_B0015) consisting of BBa_B0010 and | The part includes a double terminator (BBa_B0015) consisting of BBa_B0010 and | ||
BBa_B0012. It works in the forward direction with a forward efficiency of 0.984[CC] and 0.97[JK]. | BBa_B0012. It works in the forward direction with a forward efficiency of 0.984[CC] and 0.97[JK]. | ||
| − | |||
BBa_K206000 is an arabinose induced e.coli promoter. We decided to work with Arabinose | BBa_K206000 is an arabinose induced e.coli promoter. We decided to work with Arabinose | ||
| Line 32: | Line 28: | ||
and differentiation, inhibits proliferation of tumorous cells in colon flora. | and differentiation, inhibits proliferation of tumorous cells in colon flora. | ||
It is produced by the bacterial fermantation of carbohydrates in colon. (2) | It is produced by the bacterial fermantation of carbohydrates in colon. (2) | ||
| − | |||
Butyrate is formed by many pathways which one of them begins with Acetyl-CoA. Acetyl-CoA | Butyrate is formed by many pathways which one of them begins with Acetyl-CoA. Acetyl-CoA | ||
is readily present in the cells so we wanted to find an enzyme that directly | is readily present in the cells so we wanted to find an enzyme that directly | ||
| Line 53: | Line 48: | ||
converts it to butyrate, which is ButCoaT. ButCoaT converts acetyl CoA to | converts it to butyrate, which is ButCoaT. ButCoaT converts acetyl CoA to | ||
butyrate by the reaction Butanoyl-CoA + Acetate <=> Butanoic acid + Acetyl-CoA. And BBa_K2052018 | butyrate by the reaction Butanoyl-CoA + Acetate <=> Butanoic acid + Acetyl-CoA. And BBa_K2052018 | ||
| − | is the sequence which codes for ButCoaT | + | is the sequence which codes for ButCoaT. |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
Revision as of 11:16, 16 October 2016
FimH site directed mutated with RPMrel and ButCoat
This part is composed of a protein coding section (fimH+ RPMrel), a double
terminator, arabinose induced promoter, RBS and another protein coding sequence
(ButCoaT).
FimH protein is a subunit of a structure called pilus, which naturally occurs in some
strains of e.coli. This protein coding sequence made our bacteria to have fimH adhesin. Normally, in pathogenic strains of E.coli, at the end of each pilus, there is a carbohydrate binding protein “Lectin” which allows the binding to sugar mannose. However, we used a non- pathogenic strain BL21 in our project so it doesn’t contain Lectin in it’s pili. Thus our bacteria isn’t able to bind to bind to any non-cancerous eukaryotic cells even though it had fimH. Then, to make the binding system cancer specific and to make our bacteria bind only to cancerous cells, we used RPMrel. RPMrel is a 9 amino acid colon tumor specific binding heptapeptide. It was used for controlling preferential binding to poorly-differentiated colon carcinoma cells. (1)
The part includes a double terminator (BBa_B0015) consisting of BBa_B0010 and BBa_B0012. It works in the forward direction with a forward efficiency of 0.984[CC] and 0.97[JK].
BBa_K206000 is an arabinose induced e.coli promoter. We decided to work with Arabinose Induced Promoter in the middle of our construct to understand if FimH works without putting arabinose and if ButCoaT works with arabinose in the medium.
BBa_B0034 is a ribosome binding site with the efficiency of 1. It is responsible for the recruitment of the ribosomes during the initiation of protein translation.
In order to kill cancerous cells, we decided to overproduce butyrate. Butyrate is a four carbon, short chain fatty acid that inhibits cancer. It induces apoptosis
and differentiation, inhibits proliferation of tumorous cells in colon flora.
It is produced by the bacterial fermantation of carbohydrates in colon. (2)
Butyrate is formed by many pathways which one of them begins with Acetyl-CoA. Acetyl-CoA
is readily present in the cells so we wanted to find an enzyme that directly
converts it to butyrate, which is ButCoaT. ButCoaT converts acetyl CoA to
butyrate by the reaction Butanoyl-CoA + Acetate <=> Butanoic acid + Acetyl-CoA. And BBa_K2052018
is the sequence which codes for ButCoaT.
Reference
1. Kelly, K. A., Jones, D. A., (2003). Isolation of a Colon Tumor Specific Binding Peptide Using Phage Display Selection
2. Hassig, C.A., Tong, J.K., Schreiber, S.L. (1997). Fiber-derived Butyrate and the Prevention of Colon Cancer
Butyrate is a four carbon, short chain fatty acid that inhibits cancer. It induces apoptosis and differentiation, inhibits proliferation of tumorous cells in colon flora. It is produced by the bacterial fermantation of carbohydrates in colon. Butyrate is formed by many pathways which one of them begins with Acetyl-CoA. Acetyl-CoA is readily present in the cells so we wanted to find an enzyme that directly converts it to butyrate, which is ButCoaT. ButCoaT converts acetyl CoA to butyrate by the reaction Butanoyl-CoA + Acetate <=> Butanoic acid + Acetyl-CoA. And BBa_K2052018 is the sequence which codes for ButCoaT.